Thursday, February 8, 2018, San Francisco, California, 6:45 PM – 8:45 PM (Pacific Time)

Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Management of Advanced Prostate Cancer

Location:
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Time:
6:15 PM – 6:45 PM (Pacific Time) — Registration and Dinner Buffet
6:45 PM – 8:45 PM (Pacific Time) — Educational Meeting

Meeting Room:
Yerba Buena Ballroom, Salon 9-15 (Lower B2 Level)

There is no registration fee for this event. However, preregistration is advised as seating is limited.

Faculty:
Robert Dreicer, MD, MS
Section Head, Medical Oncology
Deputy Director
University of Virginia Cancer Center
Associate Director for Clinical Research
Co-Director
Paul Mellon Urologic Cancer Institute
Professor of Medicine and Urology
University of Virginia School of Medicine
Charlottesville, Virginia

Karim Fizazi, MD, PhD 
Head of the Department of Cancer Medicine
Institute Gustave Roussy
Professor in Oncology
University of Paris
Villejuif, France

Daniel P Petrylak, MD
Professor of Medicine
Director, Prostate and GU Medical Oncology
Co-Director, Signal Transduction Program
Yale Cancer Center
New Haven, Connecticut

Oliver Sartor, MD
CE and Bernadine Laborde
Professor for Cancer Research
Medical Director, Tulane Cancer Center
Assistant Dean for Oncology
Tulane Medical School
New Orleans, Louisiana

Mary-Ellen Taplin, MD
Chair, Executive Committee for Clinical Research
Director of Clinical Research
Lank Center for Genitourinary Oncology
Institute Physician
Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

Moderator:
Neil Love, MD
Research To Practice
Miami, Florida

Not an official event of the 2018 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by any of the cosponsoring organizations of the 2018 Genitourinary Cancers Symposium.

6:15 PM – 6:45 PM (Pacific Time) — Registration and Dinner Buffet
6:45 PM – 8:45 PM (Pacific Time) — Educational Meeting

Overview
This symposium will focus on the discussion of actual cases of prostate cancer (PC) provided by 5 investigators specializing in the management of advanced PC who will serve as the faculty. Research To Practice (RTP) president and medical oncologist Dr Neil Love will moderate the symposium. Leading up to the conference, Penn State College of Medicine and RTP will recruit 20 additional PC investigators who, along with the faculty, will participate in a unique educational assessment designed to document their collective practice patterns related to an array of common and less frequently encountered clinical scenarios. Key data points from this assessment will be used to formulate the program agenda, which will be divided into 5 modules. Each module will feature a faculty member-led review of emerging and ongoing research and a corresponding panel discussion related to the presentation and relevant data points generated from the premeeting expert assessment. Clinician attendees will use iPads® to complete a similar survey, and the results from both cohorts will be juxtaposed throughout the event to foster additional discussion and debate.

Topics for Discussion

MODULE 1: Existing and Emerging Therapeutic Strategies for the Management of M0 Disease

MODULE 2: Management of Hormone-Sensitive Metastatic PC

MODULE 3: Clinical Algorithms for Patients with Metastatic Castration-Resistant PC

MODULE 4: Bone-Targeted Therapies and Other Emerging Radiopharmaceutical Agents

MODULE 5: Other Promising Novel Agents and Strategies Under Investigation

Full agenda to be announced in January 2018.

Target Audience:
This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare professionals involved in the treatment of prostate cancer (PC).

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Appraise recent data on diagnostic and therapeutic advances in PC, and integrate this information, as appropriate, into current clinical care.
  • Evaluate emerging clinical trial data with the use of available and investigational immunotherapeutic, chemotherapeutic and secondary hormonal agents in the management of nonmetastatic PC, and consider this information in the discussion of protocol and nonresearch treatment options.
  • Explore available data with the use of cytotoxic and secondary hormonal therapy in the setting of hormone-sensitive metastatic PC, and consider this information when designing treatment plans for appropriate individuals.
  • Effectively apply evidence-based research findings in the determination of best-practice sequencing of available immunotherapeutic, chemotherapeutic and secondary hormonal agents for patients with metastatic castration-resistant PC.
  • Consider available research data and expert perspectives on the efficacy and safety of radium-223 chloride as monotherapy or in combination with other treatment modalities for advanced PC, and use this information to appropriately integrate this radiopharmaceutical agent into clinical practice.
  • Counsel appropriately selected patients with PC about the availability of and participation in ongoing clinical trials.

CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and Research To Practice. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
It is the policy of Research To Practice and Penn State College of Medicine to ensure balance, independence, objectivity and scientific rigor in all their educational programs. All faculty, planners and managers participating in this activity are required to disclose any relevant financial relationship(s) they (or spouse/partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interest. Research To Practice and Penn State College of Medicine will ensure that any conflicts of interest are resolved before the educational activity occurs. Financial disclosures will be provided in meeting course materials.

Supporters:
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Sanofi Genzyme.

San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Meeting Room:
Yerba Buena Ballroom, Salon 9-15 (Lower B2 Level)

Directions:
The San Francisco Marriott Marquis is located just 2 blocks (less than 0.2 miles) from the Moscone Center, where the 2018 Genitourinary Cancers Symposium is taking place.

 

This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare professionals involved in the treatment of prostate cancer.

There is no registration fee for this event. However, preregistration is advised as seating is limited.

Registration for clinicians in practice

I am a practicing physician, nurse, fellow or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
Registration for other/industry professionals*

Please note, a limited number of seats are currently available for nonclinicians on a first come, first served basis.

Registration for industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least 30 minutes prior to the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CME/CNE programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.